HIPAA Alert: Potential Data Breach Learn More

Search
Close this search box.

Deric M. Park, MD, FACP

Board Certifications: Neurology

Languages: English and Korean

Locations: Hackensack, NJ

Call Hackensack, NJ: (551) 996-5900

Academic Appointments and Achievements

Awards and Honors
Castle Connolly Top Doctors: 2021, 2022, 2023
Chicago Magazine Top Brain Doctors: 2022
American Society of Clinical Oncology: Career Development Award (Mentor: Merrill Egorin)
Research Award: Chordoma Foundation
Travel Award, AACR-ASCO Methods in Clinical Cancer Research Workshop
Hillman Foundation Fellow in Innovative Cancer Research
The Gregory T.H. Davies Chair in Brain Tumor Research and Physician Education

Professional Memberships
American College of Physicians
Scientific Advisory Board, The Chordoma Foundation
Scientific Advisor, Innate Repair

Education

Medical Education
BA, History, Pacific Union College, Angwin, CA
MD, Loma Linda University, Loma Linda, CA
Post-Sophomore Fellow, Department of Pathology and Anatomy, Loma Lindam University, Loma Linda, CA
Neuro-Oncology Fellow, Memorial Sloan-Kettering Cancer Center, New York, NY
Postdoctoral Research Fellow in Immunology and Cell Biology, NINDS, National Institutes of Health, Bethesda, MD

Residency
Neurology Residency (Chief 1999-2000), University of Chicago, Chicago, IL

Fellowships
Neuro-Oncology Fellow, Memorial Sloan-Kettering Cancer Center, New York, NY
Postdoctoral Research Fellow in Immunology and Cell Biology, NINDS, National Institutes of Health, Bethesda, MD

Locations

Patients may schedule appointments with Dr. Park at:

92 2nd St
Hackensack, NJ, 07601

Fax:

Hospital Affiliations

John Theurer Cancer Center

We are here for you

For more information or to schedule an appointment, call 844-346-7222. You can also schedule an appointment by calling the RCCA location nearest you.

Regional Cancer Care Associates is one of fewer than 200 medical practices in the country selected to participate in the Oncology Care Model (OCM); a recent Medicare initiative aimed at improving care coordination and access to and quality of care for Medicare beneficiaries undergoing chemotherapy treatment.